 FINANCIAL HIGHLIGHTS • Scapa achieved significant goals this  year – Healthcare exceeded £100m in  sales, Industrial achieved double-digit  margins, and the Company achieved  £500m market capitalisation • Revenue, trading profit and margins  grew for the seventh consecutive  year, showing the benefit of a  consistent and well executed strategy • Revenue increased to £279.6m,  helped by currency tailwinds and the  acquisition of EuroMed • Trading profit increased to £29.2m  with both businesses contributing well • Margins increased to 10.4% as the  Industrial ROCE strategy continues  to deliver  • This strong performance results in  an adjusted EPS increase of 39.6%,  supporting an increase in the  dividend to 2.0p from 1.75p * Operating profit before amortisation of intangible assets, exceptional items and pension administration costs ** Adjusted for exceptional items, amortisation of intangible assets, pension administration costs, non-cash interest, and the tax thereon STRATEGIC REPORT SCAPA GROUP PLC ANNUAL REPORT AND ACCOUNTS 2017 1 £116.4m (2016: £103.4m) £14.4m (2016: £14.0m) £148.8m (2016: £129.3m) CHAIRMAN’S LETTER 4 SECTION TITLE: PAGE REF 4 STRATEGIC REPORT adhesive based value chain at our strategic  customers. The Industrial business continues to  deliver impressive results through focus on  Return on Capital Employed (ROCE) and  operational efficiency. Estimated at  over US$30 billion, its growth reflects the  GDP of the markets. We recognised that  to deliver the double-digit profit growth we  could not rely solely on revenue growth,  particularly given the uncertain and endemic  macro environment. We have, along the way, accumulated  capabilities and competencies that are  yielding significant results. We believe we can achieve our new  goal by continuing to execute our self-help  agenda. Group revenue increased 13.3% to  £279.6m (2016: £246.7m) and trading profit  increased 37.1% to £29.2m (2016: £21.3m),  with strong trading helped by a currency  translation tailwind. Group margins  increased to 10.4% from 8.6%. This year has seen a further strengthening  of the Balance Sheet, including continued  actions to manage the legacy pension  scheme deficit. EBITDA comprises  trading profit before depreciation. Subject to  approval of shareholders at the forthcoming  Annual General Meeting the dividend will 4 SECTION TITLE: PAGE REF SCAPA GROUP PLC ANNUAL REPORT AND ACCOUNTS 2017 5 4 STRATEGIC REPORT CHIEF EXECUTIVE’S STRATEGIC REVIEW “ T H E F IN A N CI A L  ACCOMPLISHMENTS  ARE THE RESULT OF  OUR RELENTLESS AND  UNCOMPROMISING  EXECUTION OF  THE STRATEGY.” In Healthcare our strategy is to be the  strategic turn-key